Enhanced number and activity of mitochondria in multiple sclerosis lesions

Journal of Pathology

Volumn 219, Issue 2, 2009, Pages 193-204

  Witte, Maarten E ^a   Lars, B o ^b   Rodenburg, Richard J ^c   Belien, Jeroen A ^a   Musters, Rene ^a   Hazes, Thierry ^a   Wintjes, Liesbeth T ^c   Smeitink, Jan A ^c   Geurts, Jeroen J G ^a   De Vries, Helga E ^a   Van Der Valk, Paul ^a   Van Horssen, Jack ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Astrocytes; Axon; Mitochondria; Multiple sclerosis; Oxidative stress

Indexed keywords

CYTOCHROME C OXIDASE; HEAT SHOCK PROTEIN 70; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN DAMAGE; BRAIN MITOCHONDRION; CELL DENSITY; CELLULAR DISTRIBUTION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; AXONS; BRAIN; ELECTRON TRANSPORT COMPLEX IV; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSCOPY, CONFOCAL; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; UP-REGULATION; YOUNG ADULT;

EID: 70349135156     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2582     Document Type: Article

References (49)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.
2. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120(3):393-399. (Pubitemid 27153632)
3. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285. (Pubitemid 28065253)
4. Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295-302. (Pubitemid 29378163)
5. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121(8):1469-1477. (Pubitemid 28349900)
6. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000;157:267-276. (Pubitemid 30641742)
7. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000;48:893-901.
8. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999;25:459-467. (Pubitemid 30045420)
9. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004;251:261-268. (Pubitemid 38387142)
10. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 2005;7:1223-1233. (Pubitemid 41232519)
11. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 2005;70:200-214. (Pubitemid 40512329)
12. Sas K, Robotka H, Toldi J, Vecsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007;257:221-239. (Pubitemid 46856508)
13. Schreibelt G, Van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 2007;56:322-330. (Pubitemid 350166526)
14. Mitsumoto A, Takeuchi A, Okawa K, Nakagawa Y. A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress. Free Radic Biol Med 2002;32:22-37. (Pubitemid 34045134)
15. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006;59:478-489. (Pubitemid 43358068)
16. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000;177:95-103. (Pubitemid 30687389)
17. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci 2007;48:681-691. (Pubitemid 351260701)
18. Kalman B, Lublin FD, Alder H. Characterization of the mitochondrial DNA in patients with multiple sclerosis. J Neurol Sci 1996;140:75-84. (Pubitemid 26273622)
19. Kalman B, Li S, Chatterjee D, O'Connor J, Voehl MR, Brown MD, et al. Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 1999;99:16-25. (Pubitemid 29012613)
20. Kalman B, Lublin FD, Alder H. Mitochondrial DNA mutations in multiple sclerosis. Mult Scler 1995;1:32-36.
21. Olsen NK, Hansen AW, Norby S, Edal AL, Jorgensen JR, Rosenberg T. Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation. Acta Neurol Scand 1995;91:326-329.
22. Kalman B, Alder H. Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis? Acta Neurol Scand 1998;98:232-237. (Pubitemid 28462080)
23. + exchanger. Proc Natl Acad Sci USA 2004;101:8168-8173.
24. Andrews H, White K, Thomson C, Edgar J, Bates D, Griffiths I, et al. Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J Neurosci Res 2006;83:1533-1539. (Pubitemid 43844998)
25. De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001;124:1635-1645. (Pubitemid 32726776)
26. Van Der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000;26:2-10. (Pubitemid 30145301)
27. Wouterlood FG, Boekel AJ, Meijer GA, Belien JA. Computer-assisted estimation in the CNS of 3D multimarker 'overlap' or 'touch' at the level of individual nerve endings: a confocal laser scanning microscope application. J Neurosci Res 2007;85:1215-1228.
28. Wouterlood FG, Boekel AJ, Kajiwara R, Belien JA. Counting contacts between neurons in 3D in confocal laser scanning images. J Neurosci Methods 2008;171:296-308.
29. Seligman AM, Karnovsky MJ, Wasserkrug HL, Hanker JS. Non-droplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol 1968;38:1-14.
30. Srere PA. Citrate synthase. Methods Enzymol 1969;13:3-11.
31. Cooperstein SJ, Lazarow A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem 1951;189:665-670.
32. Mahad D, Ziabreva I, Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008;131:1722-1735. (Pubitemid 351957459)
33. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-717. (Pubitemid 30390191)
34. Breij EC, Brink BP, Veerhuis R, van den BC, Vloet R, Yan R, et al. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 2008;63:16-25. (Pubitemid 351240547)
35. Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, et al. Mitochondrial changes within axons in multiple sclerosis. Brain 2009;(in press).
36. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996;328:85-92. (Pubitemid 26108173)
37. 2+ exchanger. J Neurosci 1992;12:430-439.
38. Williams A, Piaton G, Lubetzki C. Astrocytes - friends or foes in multiple sclerosis? Glia 2007;55:1300-1312. (Pubitemid 47328934)
39. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, et al. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 2007;18:52-61.
40. Jack C, Antel J, Bruck W, Kuhlmann T. Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis. Glia 2007;55:926-934. (Pubitemid 46903993)
41. Satoh J, Tabunoki H, Nanri Y, Arima K, Yamamura T. Human astrocytes express 14-3-3 σ in response to oxidative and DNA-damaging stresses. Neurosci Res 2006;56:61-72. (Pubitemid 44404048)
42. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431-437.
43. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-487.
44. Vladimirova O, Lu FM, Shawver L, Kalman B. The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls. Inflamm Res 1999;48:412-416. (Pubitemid 29361251)
45. Oleszak EL, Zaczynska E, Bhattacharjee M, Butunoi C, Legido A, Katsetos CD. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin Diagn Lab Immunol 1998;5:438-445. (Pubitemid 28342866)
46. Gibson CL, Coughlan TC, Murphy SP. Glial nitric oxide and ischemia. Glia 2005;50:417-426.
47. Kaul SC, Deocaris CC, Wadhwa R. Three faces of mortalin: a housekeeper, guardian and killer. Exp Gerontol 2007;42:263-274. (Pubitemid 46356847)
48. Voloboueva LA, Duan M, Ouyang Y, Emery JF, Stoy C, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 protects astrocytes against ischemic injury in vitro. J Cereb Blood Flow Metab 2008;28:1009-1016. (Pubitemid 351589637)
49. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004;279:34682-34690. (Pubitemid 39318098)